SCHEMBL1163245

SCHEMBL1163245

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CCCC(N)[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.68
▸ CYP2C19 P33261 1/20 0.68
▸ INPP5D Q92835 1/20 0.67
▸ SRD5A1 P18405 4/20 0.55
▸ SRD5A2 P31213 3/20 0.55
▸ CDC25A P30304 4/20 0.54
▸ POLA1 P09884 1/20 0.53
▸ NPC1L1 Q9UHC9 2/20 0.53
▸ LMNA P02545 3/20 0.50
▸ FNTA P49354 2/20 0.50
▸ FNTB P49356 2/20 0.50
▸ AKR1B10 O60218 1/20 0.50
▸ AKR1B1 P15121 1/20 0.50
▸ EFNA1 P20827 1/20 0.50
▸ EPHA2 P29317 1/20 0.50
▸ PSEN1 P49768 1/20 0.50
▸ PSEN2 P49810 1/20 0.50
▸ GPBAR1 Q8TDU6 1/20 0.50
▸ APH1B Q8WW43 1/20 0.50
▸ NCSTN Q92542 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6847205 1.00 CYP2D6 (0.68) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL29011064 0.88 CYP2D6 (0.63) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL28408 0.87 CYP2D6 (0.65) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL3447573 0.87 CYP2D6 (0.65) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL28788280 0.87 CYP2D6 (0.62) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL133952 0.87 CYP2D6 (0.65) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL9224303 0.87 CYP2D6 (0.65) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
Water SCHEMBL4949873 0.86 CYP2D6 (0.64) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL28358894 0.86 CYP2D6 (0.61) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2
SCHEMBL16226626 0.86 NPC1L1 (0.64) CYP2D6CYP2C19INPP5DSRD5A1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011019942-A2 SYNTHETIC CHOLESTERYLAMINE-LINKER DERIVATIVES FOR AGENT DELIVERY INTO CELLS UNIVERSITY OF KANSAS (US) 2011-02-17 — — WO disclosed
WO-2010022051-A2 DISRUPTORS OF EARLY/RECYCLING ENDOSOMES UNIVERSITY OF KANSAS (US) 2010-02-25 — — WO disclosed
Send feedback